What's in Cellid Co., Ltd.'s pipeline?

Cellid Co., Ltd. has 4 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 3 in Phase 1.

Which companies overlap with Cellid Co., Ltd.'s portfolio?

Top competitors by shared drug class: Aeras, Bharat Biotech International Limited, CanSino Biologics Inc., Crucell Holland BV, D'Or Institute for Research and Education.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/cellid-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Cellid Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cellid Co., Ltd. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
AdCLD-CoV19-1 OMI	AdCLD-CoV19-1 OMI	phase 3	Viral vector vaccine	SARS-CoV-2 Omicron variant spike protein	Immunology / Infectious Disease

Therapeutic area mix

Immunology / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Aeras · 1 shared drug class
Bharat Biotech International Limited · 1 shared drug class
CanSino Biologics Inc. · 1 shared drug class
Crucell Holland BV · 1 shared drug class
D'Or Institute for Research and Education · 1 shared drug class
EuBiologics Co.,Ltd · 1 shared drug class
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation · 1 shared drug class
Janssen Vaccines & Prevention B.V. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Cellid Co., Ltd.:

Cite this brief

Drug Landscape (2026). Cellid Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/cellid-co-ltd. Accessed 2026-06-10.